EVGN
Evogene Ltd.
Price Chart
Latest Quote
$0.52
-0.01 (-0.97%)
Current Price
| Previous Close | $0.53 |
| Open | $0.52 |
| Day High | $0.53 |
| Day Low | $0.52 |
| Volume | 29,723 |
Stock Information
| Shares Outstanding | 12.10M |
| Total Debt | $2.03M |
| Cash Equivalents | $13.05M |
| Revenue | $1.84M |
| Net Income | $-18.54M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $6.29M |
| EPS (TTM) | $-1.70 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.98M |
| Sales | $1.84M |
| Income | $-18.54M |
| Book/sh | $-0.24 |
| Cash/sh | $1.08 |
| Employees | 52 |
Financial Ratios
| Quick Ratio | 2.75 |
| Current Ratio | 2.79 |
| Debt/Eq | 25.42 |
Returns & Margins
| ROA | -32.89% |
| ROE | -171.75% |
| Gross Margin | -46.80% |
| Operating Margin | -952.10% |
Ownership
| Insider Ownership | 0.96% |
| Institutional Ownership | 6.25% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.65 |
| P/S | 3.41 |
| P/B | -2.13 |
Analyst Data
| Recommendation | none |
| Target Price | $2.15 |
Technical Indicators
| SMA20 | $0.62 |
| SMA50 | $0.71 |
| SMA200 | $0.98 |
| RSI | 19.23 |
| ATR | 0.0600 |
| Shares Float | 10.33M |
| Short Float | 1.19% |
| Short Ratio | 2.02 |
| Volatility | 0.74 |
| Rel Volume | 0.02 |
Performance History
| Week | -10.34% |
| Month | -27.78% |
| Quarter | -38.82% |
| 6 Months | -48.51% |
| YTD | -53.98% |
| Year | -67.09% |
| 3 Years | -93.33% |
| 5 Years | -98.59% |
| 10 Years | -99.16% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $0.52 | 29,723 |
| 2026-06-18 | $0.53 | 229,400 |
| 2026-06-17 | $0.56 | 311,700 |
| 2026-06-16 | $0.56 | 174,400 |
| 2026-06-15 | $0.58 | 154,200 |
| 2026-06-12 | $0.58 | 126,800 |
| 2026-06-11 | $0.59 | 168,800 |
| 2026-06-10 | $0.59 | 198,300 |
| 2026-06-09 | $0.60 | 311,400 |
| 2026-06-08 | $0.58 | 378,200 |
| 2026-06-05 | $0.62 | 390,500 |
| 2026-06-04 | $0.61 | 733,800 |
| 2026-06-03 | $0.60 | 900,000 |
| 2026-06-02 | $0.59 | 24,934,300 |
| 2026-06-01 | $0.68 | 40,700 |
| 2026-05-29 | $0.71 | 36,100 |
| 2026-05-28 | $0.72 | 33,900 |
| 2026-05-27 | $0.71 | 62,400 |
| 2026-05-26 | $0.71 | 76,900 |
| 2026-05-22 | $0.70 | 58,600 |
About Evogene Ltd.
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
đ° Latest News
Evogene Ltd (EVGN) Q1 2026 Earnings Call Highlights: Strategic Collaborations Amid Financial ...
GuruFocus.com âĸ 2026-05-29T01:00:40ZEvogene Ltd. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-20T16:43:26Z
Evogene Shares Decline After Revenue Miss Despite Stronger-Than-Expected Earnings (EVGN)
InvestorsHub âĸ 2026-05-20T13:59:09Z
Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline
GuruFocus.com âĸ 2026-03-14T01:01:01ZEvogene Ltd. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-06T13:30:00Z
Evogene: Q4 Earnings Snapshot
Associated Press Finance âĸ 2026-03-05T12:32:32ZEvogene: Q3 Earnings Snapshot
Associated Press Finance âĸ 2025-11-20T12:12:16ZEvogene Declares The Sale Of Lavie Bioâs Activity To ICL Completed
Insider Monkey âĸ 2025-08-24T05:37:28Z
Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...
GuruFocus.com âĸ 2025-08-20T07:05:18Z
Evogene: Q2 Earnings Snapshot
Associated Press Finance âĸ 2025-08-19T11:10:43Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $4,094,000 | $2,380,000 | $1,490,000 | $909,000 |
| Cost Of Revenue | $4,094,000 | $2,380,000 | $1,490,000 | $909,000 |
| Total Revenue | $3,853,000 | $5,577,000 | $2,982,000 | $1,675,000 |
| Operating Revenue | $3,853,000 | $5,577,000 | $2,982,000 | $1,675,000 |
| Expenses | ||||
| Interest Expense | $157,000 | $63,000 | $114,000 | $165,000 |
| Total Expenses | $17,887,000 | $24,381,000 | $25,213,000 | $28,616,000 |
| Other Income Expense | $1,821,000 | $3,725,000 | $-430,000 | $-2,576,000 |
| Net Non Operating Interest Income Expense | $-1,285,000 | $271,000 | $715,000 | $-237,000 |
| Total Other Finance Cost | $1,484,000 | $481,000 | $149,000 | $254,000 |
| Interest Expense Non Operating | $157,000 | $63,000 | $114,000 | $165,000 |
| Operating Expense | $13,793,000 | $22,001,000 | $23,723,000 | $27,707,000 |
| Other Operating Expenses | $37,000 | $514,000 | - | $-3,500,000 |
| Selling And Marketing Expense | $185,000 | $224,000 | $162,000 | $132,000 |
| General And Administrative Expense | $5,577,000 | $8,752,000 | $7,365,000 | $10,283,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-14,157,000 | $-13,248,000 | $-19,890,000 | $-26,638,000 |
| Net Interest Income | $-1,285,000 | $271,000 | $715,000 | $-237,000 |
| Interest Income | $356,000 | $815,000 | $978,000 | $182,000 |
| Normalized Income | $-15,589,200 | $-16,146,280 | $-19,558,900 | $-24,654,480 |
| Net Income From Continuing And Discontinued Operation | $-8,485,000 | $-16,485,000 | $-23,879,000 | $-26,638,000 |
| Total Operating Income As Reported | $-14,034,000 | $-18,804,000 | $-22,231,000 | $-26,941,000 |
| Net Income Common Stockholders | $-8,485,000 | $-16,485,000 | $-23,879,000 | $-26,638,000 |
| Net Income | $-8,485,000 | $-16,485,000 | $-23,879,000 | $-26,638,000 |
| Net Income Including Noncontrolling Interests | $-7,827,000 | $-18,054,000 | $-25,954,000 | $-29,844,000 |
| Net Income Discontinuous Operations | $5,672,000 | $-3,237,000 | $-3,989,000 | - |
| Net Income Continuous Operations | $-13,499,000 | $-14,817,000 | $-21,965,000 | $-29,844,000 |
| Pretax Income | $-13,498,000 | $-14,808,000 | $-21,946,000 | $-29,754,000 |
| Earnings From Equity Interest | $-39,000 | $-39,000 | $0 | $0 |
| Interest Income Non Operating | $356,000 | $815,000 | $978,000 | $182,000 |
| Operating Income | $-14,034,000 | $-18,804,000 | $-22,231,000 | $-26,941,000 |
| Gross Profit | $-241,000 | $3,197,000 | $1,492,000 | $766,000 |
| Per Share | ||||
| Diluted EPS | $-1.08 | $-2.89 | $-5.20 | $-6.50 |
| Basic EPS | $-1.08 | $-2.89 | $-5.20 | $-6.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $427,800 | $865,720 | $-98,900 | $-592,480 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-14,057,000 | $-17,128,000 | $-20,102,000 | $-24,433,000 |
| Total Unusual Items | $1,860,000 | $3,764,000 | $-430,000 | $-2,576,000 |
| Total Unusual Items Excluding Goodwill | $1,860,000 | $3,764,000 | $-430,000 | $-2,576,000 |
| Reconciled Depreciation | $1,144,000 | $1,381,000 | $1,300,000 | $2,580,000 |
| EBITDA (Bullshit earnings) | $-12,197,000 | $-13,364,000 | $-20,532,000 | $-27,009,000 |
| EBIT | $-13,341,000 | $-14,745,000 | $-21,832,000 | $-29,589,000 |
| Diluted Average Shares | $7,874,039 | $5,697,245 | $4,568,561 | $4,121,018 |
| Basic Average Shares | $7,874,039 | $5,697,245 | $4,568,561 | $4,121,018 |
| Diluted NI Availto Com Stockholders | $-8,485,000 | $-16,485,000 | $-23,879,000 | $-26,638,000 |
| Minority Interests | $-658,000 | $1,569,000 | $2,075,000 | $3,206,000 |
| Tax Provision | $1,000 | $9,000 | $19,000 | $90,000 |
| Gain On Sale Of Security | $1,860,000 | $3,764,000 | $-430,000 | $-2,576,000 |
| Research And Development | $7,994,000 | $12,511,000 | $16,196,000 | $20,792,000 |
| Selling General And Administration | $5,762,000 | $8,976,000 | $7,527,000 | $10,415,000 |
| Other Gand A | $4,733,000 | $7,267,000 | $5,844,000 | $4,286,000 |
| Salaries And Wages | $844,000 | $1,485,000 | $1,521,000 | $5,997,000 |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-82,000 | $-13,646,000 | $-1,116,000 | $13,790,000 |
| Total Assets | $20,046,000 | $39,864,000 | $51,101,000 | $56,126,000 |
| Total Non Current Assets | $4,415,000 | $18,275,000 | $16,632,000 | $18,375,000 |
| Non Current Prepaid Assets | $571,000 | $12,000 | $28,000 | $74,000 |
| Non Current Deferred Assets | $1,165,000 | $1,735,000 | $0 | $94,000 |
| Goodwill And Other Intangible Assets | $0 | $12,195,000 | $13,169,000 | $14,140,000 |
| Current Assets | $15,631,000 | $21,589,000 | $34,469,000 | $37,751,000 |
| Current Deferred Assets | $551,000 | $1,304,000 | $0 | - |
| Restricted Cash | $32,000 | $10,000 | $0 | $32,000 |
| Prepaid Assets | $504,000 | $1,668,000 | $2,526,000 | $995,000 |
| Inventory | $210,000 | $1,819,000 | $76,000 | $566,000 |
| Receivables | $1,378,000 | $1,487,000 | $804,000 | $803,000 |
| Other Receivables | $1,061,000 | $396,000 | $447,000 | $455,000 |
| Accounts Receivable | $317,000 | $1,091,000 | $357,000 | $348,000 |
| Cash Cash Equivalents And Short Term Investments | $12,956,000 | $15,301,000 | $31,063,000 | $35,355,000 |
| Cash And Cash Equivalents | $12,956,000 | $15,301,000 | $20,772,000 | $28,980,000 |
| Cash Financial | $12,956,000 | $15,301,000 | $20,772,000 | $28,980,000 |
| Non Current Deferred Taxes Assets | - | $1,735,000 | $0 | $94,000 |
| Other Intangible Assets | - | $12,195,000 | $13,169,000 | $14,140,000 |
| Accrued Interest Receivable | - | - | $1,617,000 | $0 |
| Non Current Accounts Receivable | - | - | - | $74,000 |
| Debt | ||||
| Total Debt | $2,198,000 | $12,874,000 | $11,506,000 | $11,930,000 |
| Long Term Debt And Capital Lease Obligation | $1,482,000 | $1,914,000 | $10,653,000 | $11,046,000 |
| Current Debt And Capital Lease Obligation | $716,000 | $10,960,000 | $853,000 | $884,000 |
| Current Debt | - | $10,371,000 | - | - |
| Other Current Borrowings | - | $10,371,000 | - | - |
| Long Term Debt | - | - | $10,368,000 | $10,114,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,071,000 | $25,026,000 | $22,416,000 | $21,336,000 |
| Total Non Current Liabilities Net Minority Interest | $4,627,000 | $6,331,000 | $15,472,000 | $15,711,000 |
| Non Current Deferred Liabilities | $3,145,000 | $4,417,000 | $4,819,000 | $4,665,000 |
| Current Liabilities | $3,444,000 | $18,695,000 | $6,944,000 | $5,625,000 |
| Other Current Liabilities | $706,000 | $2,876,000 | - | - |
| Current Deferred Liabilities | $73,000 | $683,000 | $750,000 | $101,000 |
| Payables And Accrued Expenses | $1,949,000 | $4,176,000 | $5,341,000 | $4,640,000 |
| Payables | $1,088,000 | $2,307,000 | $2,804,000 | $2,653,000 |
| Other Payable | $449,000 | $1,079,000 | $1,019,000 | $1,617,000 |
| Accounts Payable | $639,000 | $1,228,000 | $1,785,000 | $1,036,000 |
| Equity | ||||
| Common Stock Equity | $-82,000 | $-1,451,000 | $12,053,000 | $27,930,000 |
| Total Equity Gross Minority Interest | $11,975,000 | $14,838,000 | $28,685,000 | $34,790,000 |
| Stockholders Equity | $-82,000 | $-1,451,000 | $12,053,000 | $27,930,000 |
| Retained Earnings | $-282,556,000 | $-274,071,000 | $-257,586,000 | $-233,707,000 |
| Long Term Equity Investment | $43,000 | $82,000 | $0 | - |
| Other | ||||
| Ordinary Shares Number | $8,718,193 | $6,514,589 | $5,058,488 | $4,126,043 |
| Share Issued | $8,718,193 | $6,514,589 | $5,058,488 | $4,126,043 |
| Tangible Book Value | $-82,000 | $-13,646,000 | $-1,116,000 | $13,790,000 |
| Invested Capital | $-82,000 | $8,920,000 | $22,421,000 | $38,044,000 |
| Working Capital | $12,187,000 | $2,894,000 | $27,525,000 | $32,126,000 |
| Capital Lease Obligations | $2,198,000 | $2,503,000 | $1,138,000 | $1,816,000 |
| Total Capitalization | $-82,000 | $-1,451,000 | $22,421,000 | $38,044,000 |
| Minority Interest | $12,057,000 | $16,289,000 | $16,632,000 | $6,860,000 |
| Additional Paid In Capital | $281,986,000 | $272,257,000 | $269,353,000 | $261,402,000 |
| Capital Stock | $488,000 | $363,000 | $286,000 | $235,000 |
| Common Stock | $488,000 | $363,000 | $286,000 | $235,000 |
| Non Current Deferred Revenue | $3,073,000 | $4,327,000 | $4,426,000 | $4,665,000 |
| Long Term Capital Lease Obligation | $1,482,000 | $1,914,000 | $285,000 | $932,000 |
| Current Deferred Revenue | $73,000 | $683,000 | $750,000 | $101,000 |
| Current Capital Lease Obligation | $716,000 | $589,000 | $853,000 | $884,000 |
| Current Accrued Expenses | $861,000 | $1,869,000 | $2,537,000 | $1,987,000 |
| Investments And Advances | $43,000 | $82,000 | $0 | - |
| Net PPE | $2,636,000 | $4,251,000 | $3,435,000 | $4,067,000 |
| Accumulated Depreciation | $-20,565,000 | $-20,952,000 | $-22,563,000 | $-21,016,000 |
| Gross PPE | $23,201,000 | $25,203,000 | $25,998,000 | $25,083,000 |
| Leases | $16,028,000 | $16,193,000 | $17,585,000 | $17,388,000 |
| Other Properties | $3,835,000 | $5,432,000 | $4,994,000 | $4,655,000 |
| Machinery Furniture Equipment | $3,338,000 | $3,578,000 | $3,419,000 | $3,040,000 |
| Properties | $0 | $0 | $0 | $0 |
| Investmentsin Associatesat Cost | - | $82,000 | $0 | - |
| Other Short Term Investments | - | $10,000 | $10,291,000 | $6,375,000 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | $2,537,000 | $1,987,000 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-13,637,000 | $-20,326,000 | $-22,154,000 | $-24,849,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-13,502,000 | $-19,700,000 | $-21,577,000 | $-23,678,000 |
| Cash From Discontinued Operating Activities | $-2,115,000 | $-2,181,000 | $-2,029,000 | - |
| Cash Flow From Continuing Operating Activities | $-11,387,000 | $-17,519,000 | $-19,548,000 | $-23,678,000 |
| Operating Gains Losses | $-628,000 | $-2,810,000 | $-26,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-135,000 | $-626,000 | $-577,000 | $-1,171,000 |
| Investing Cash Flow | $17,738,000 | $9,622,000 | $-4,538,000 | $13,274,000 |
| Cash From Discontinued Investing Activities | $17,744,000 | $48,000 | $-208,000 | - |
| Cash Flow From Continuing Investing Activities | $-6,000 | $9,574,000 | $-4,330,000 | $13,274,000 |
| Net Other Investing Changes | $52,000 | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,283,000 | $5,623,000 | $8,449,000 | $21,000 |
| Financing Cash Flow | $-6,602,000 | $4,656,000 | $18,152,000 | $9,343,000 |
| Cash From Discontinued Financing Activities | $-115,000 | $83,000 | $-117,000 | - |
| Cash Flow From Continuing Financing Activities | $-6,487,000 | $4,573,000 | $18,269,000 | $9,343,000 |
| Net Other Financing Charges | $-10,244,000 | $-164,000 | $10,495,000 | $10,118,000 |
| Net Common Stock Issuance | $4,283,000 | $5,623,000 | $8,449,000 | $21,000 |
| Common Stock Issuance | $4,283,000 | $5,623,000 | $8,449,000 | $21,000 |
| Other | ||||
| Repayment Of Debt | $-526,000 | $-886,000 | $-675,000 | $-803,000 |
| End Cash Position | $12,956,000 | $15,301,000 | $20,772,000 | $28,980,000 |
| Beginning Cash Position | $15,301,000 | $20,772,000 | $28,980,000 | $32,325,000 |
| Effect Of Exchange Rate Changes | $21,000 | $-49,000 | $-245,000 | $-2,284,000 |
| Changes In Cash | $-2,366,000 | $-5,422,000 | $-7,963,000 | $-1,061,000 |
| Net Issuance Payments Of Debt | $-526,000 | $-886,000 | $-675,000 | $-803,000 |
| Net Long Term Debt Issuance | $-526,000 | $-886,000 | $-675,000 | $-803,000 |
| Long Term Debt Payments | $-526,000 | $-886,000 | $-675,000 | $-803,000 |
| Net Investment Purchase And Sale | $-1,000 | $10,190,000 | $-3,779,000 | $14,445,000 |
| Sale Of Investment | $0 | $27,340,000 | $15,924,000 | $15,356,000 |
| Purchase Of Investment | $-1,000 | $-17,150,000 | $-19,703,000 | $-911,000 |
| Net PPE Purchase And Sale | $-57,000 | $-616,000 | $-551,000 | $-1,171,000 |
| Sale Of PPE | $78,000 | $10,000 | $26,000 | $0 |
| Purchase Of PPE | $-135,000 | $-626,000 | $-577,000 | $-1,171,000 |
| Taxes Refund Paid | $-11,000 | $-11,000 | $-31,000 | $-40,000 |
| Interest Received Cfo | $338,000 | $934,000 | $905,000 | $186,000 |
| Interest Paid Cfo | $-193,000 | $-67,000 | $-121,000 | $-165,000 |
| Change In Working Capital | $-1,253,000 | $-2,613,000 | $-278,000 | $-771,000 |
| Change In Other Working Capital | $-361,000 | $-559,000 | $-288,000 | $-247,000 |
| Change In Payables And Accrued Expense | $-1,585,000 | $-956,000 | $774,000 | $-1,096,000 |
| Change In Accrued Expense | $-756,000 | $-548,000 | $532,000 | $-675,000 |
| Change In Payable | $-829,000 | $-408,000 | $242,000 | $-421,000 |
| Change In Account Payable | $-259,000 | $-630,000 | $757,000 | $-469,000 |
| Change In Inventory | $-1,019,000 | $-1,277,000 | $489,000 | $-474,000 |
| Change In Receivables | $1,712,000 | $179,000 | $-1,253,000 | $1,046,000 |
| Changes In Account Receivables | $665,000 | $-627,000 | $-7,000 | $-67,000 |
| Other Non Cash Items | $-359,000 | $-768,000 | $-407,000 | $3,100,000 |
| Stock Based Compensation | $654,000 | $1,243,000 | $1,108,000 | $1,186,000 |
| Asset Impairment Charge | $2,426,000 | $0 | $0 | - |
| Deferred Tax | $-6,000 | $9,000 | $-33,000 | $90,000 |
| Deferred Income Tax | $-6,000 | $9,000 | $-33,000 | $90,000 |
| Depreciation Amortization Depletion | $1,144,000 | $1,381,000 | $1,300,000 | $2,580,000 |
| Depreciation And Amortization | $1,144,000 | $1,381,000 | $1,300,000 | $2,580,000 |
| Depreciation | $1,144,000 | $1,381,000 | $1,300,000 | $1,513,000 |
| Earnings Losses From Equity Investments | $39,000 | $39,000 | $0 | $0 |
| Gain Loss On Investment Securities | $-458,000 | $-3,374,000 | - | - |
| Gain Loss On Sale Of PPE | $-209,000 | $525,000 | $-26,000 | $0 |
| Net Income From Continuing Operations | $-13,499,000 | $-14,817,000 | $-21,965,000 | $-29,844,000 |
| Proceeds From Stock Option Exercised | - | $5,500,000 | $0 | $7,000 |
| Amortization Cash Flow | - | $974,000 | $971,000 | $1,067,000 |
| Amortization Of Intangibles | - | $974,000 | $971,000 | $1,067,000 |
| Issuance Of Debt | - | - | $0 | $10,000,000 |
| Long Term Debt Issuance | - | - | $0 | $10,000,000 |
| Change In Prepaid Assets | - | - | - | - |
Fetched: 2026-06-19